Search by Drug Name or NDC

    NDC 68382-0133-05 Divalproex Sodium 250 mg/1 Details

    Divalproex Sodium 250 mg/1

    Divalproex Sodium is a ORAL TABLET, FILM COATED, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Zydus Pharmaceuticals USA Inc.. The primary component is DIVALPROEX SODIUM.

    Product Information

    NDC 68382-0133
    Product ID 68382-133_7e8dacdf-99f4-4f10-91a1-a817ceed50ca
    Associated GPIs
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name Divalproex Sodium
    Proprietary Name Suffix n/a
    Non-Proprietary Name Divalproex Sodium
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, FILM COATED, EXTENDED RELEASE
    Route ORAL
    Active Ingredient Strength 250
    Active Ingredient Units mg/1
    Substance Name DIVALPROEX SODIUM
    Labeler Name Zydus Pharmaceuticals USA Inc.
    Pharmaceutical Class Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA078239
    Listing Certified Through 2024-12-31

    Package

    NDC 68382-0133-05 (68382013305)

    NDC Package Code 68382-133-05
    Billing NDC 68382013305
    Package 500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (68382-133-05)
    Marketing Start Date 2013-01-07
    NDC Exclude Flag N
    Pricing Information N/A